Pharmacology of Cefaclor in Normal Volunteers and Patients with Renal Failure
- 1 June 1978
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 13 (6) , 951-954
- https://doi.org/10.1128/aac.13.6.951
Abstract
After a 500-mg dose of cefaclor, the mean peak plasma level was 12.4 μg/ml and after a 250-mg dose it was 5 μg/ml in normal volunteers. Food intake significantly reduced absorption. Probenecid prolonged plasma levels. Mean plasma half-life in normal volunteers was 0.8 h. Only about 50% of the dose was excreted in the urine within 4 h in normal volunteers. Plasma half-life in patients with renal insufficiency was only about 3 h, which suggests that cefaclor may be eliminated by nonrenal mechanisms in humans. Urinary levels of cefaclor were adequate to inhibit susceptible pathogens even in patients with moderately severe renal failure. Plasma half-life during hemodialysis was 2.1 h and rose to 2.8 h after dialysis.This publication has 14 references indexed in Scilit:
- In Vitro Activities of Five Oral Cephalosporins Against Aerobic Pathogenic BacteriaAntimicrobial Agents and Chemotherapy, 1977
- Comparison of In Vitro Antibacterial Activity of Three Oral Cephalosporins: Cefaclor, Cephalexin, and CephradineAntimicrobial Agents and Chemotherapy, 1977
- In Vitro Activity of Cefaclor, a New Orally Administered Cephalosporin AntibioticAntimicrobial Agents and Chemotherapy, 1977
- In Vitro Susceptibility Studies with Cefaclor and CephalexinAntimicrobial Agents and Chemotherapy, 1977
- Comparative Pharmacology of Cefaclor and CephalexinAntimicrobial Agents and Chemotherapy, 1977
- Comparison of In Vitro Activity of Cephalexin, Cephradine, and CefaclorAntimicrobial Agents and Chemotherapy, 1977
- Metabolism of [ 14 C]Cefaclor, a Cephalosporin Antibiotic, in Three Species of Laboratory AnimalsAntimicrobial Agents and Chemotherapy, 1976
- Pharmacology of Cefazolin in Patients with Normal and Abnormal Renal FunctionThe Journal of Infectious Diseases, 1973
- Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.1971
- Cephalexin Therapy as Related to Renal FunctionThe Lancet Healthy Longevity, 1970